AXGN
Axogen, Inc.
Nasdaq Electromedical & Electrotherapeutic Apparatus Large accelerated filer

Key Financials

Net Income
$-15703000
↓ 57.6%
Gross Profit
$167.4M
↑ 17.9%
Operating Income
$-7849000
↓ 138.8%
Revenue
$225.2M
↑ 20.2%
EPS (Diluted)
$-0.34
↓ 47.8%
Shareholders' Equity
$128.8M
↑ 24.0%
Total Liabilities
$92.8M
↓ 7.0%
Total Assets
$221.7M
↑ 8.8%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G 10/2/2026 View on SEC
8-K 10/1/2026 View on SEC
424B5 9/10/2026 View on SEC
8-K/A 9/10/2026 View on SEC
8-K 9/10/2026 View on SEC
4 9/4/2026 View on SEC
144 9/2/2026 View on SEC
SCHEDULE 13G/A 8/14/2026 View on SEC
4 8/12/2026 View on SEC
4 8/12/2026 View on SEC

Company Information

Field Value
Ticker AXGN
Company Name Axogen, Inc.
CIK 805928
Sector Electromedical & Electrotherapeutic Apparatus
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 3845
SIC Description Electromedical & Electrotherapeutic Apparatus
Entity Type operating
Fiscal Year End 1231
State of Incorporation MN
Phone (386) 462-6817